Wikidata

(Q62025222)

English

A Study of IPL344 in the Treatment of ALS Patients

clinical trial

In more languages

Statements

short name
ALS (English)
0 references
title
Phase 1/2a, Multi-center, Open-Label, Dose-escalating Study to Assess Safety, Tolerability, and Pharmacokinetics of Intravenously Administered IPL344 for The Treatment of Amyotrophic Lateral Sclerosis (ALS) (English)
0 references
country
Israel
0 references
start time
1 August 2018
0 references
end time
15 July 2019
0 references
number of participants
15
0 references
minimum age
18 year
0 references
maximum age
80 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62025222&oldid=2136359438"